Carbonyl reduction of naltrexone and dolasetron by oxidoreductases isolated from human liver cytosol.
about
Improving clinical outcomes for naltrexone as a management of problem alcohol usePreclinical disposition (in vitro) of novel μ-opioid receptor selective antagonists.Role of metabolism in drug-induced idiosyncratic hepatotoxicity.Carbonyl reductases and pluripotent hydroxysteroid dehydrogenases of the short-chain dehydrogenase/reductase superfamily.Human microsomal carbonyl reducing enzymes in the metabolism of xenobiotics: well-known and promising members of the SDR superfamily.Carbonyl reduction pathways in drug metabolism.The modulation of carbonyl reductase 1 by polyphenols.The role of carbonyl reductase 1 in drug discovery and development.Pharmacokinetics of long-acting naltrexone in subjects with mild to moderate hepatic impairment.Single- and multiple-dose pharmacokinetics of long-acting injectable naltrexone.Pharmacogenetics of aldo-keto reductase 1C (AKR1C) enzymes.The aldo-keto reductase superfamily and its role in drug metabolism and detoxification
P2860
Q27021406-4B7F6CBF-30EB-46A2-B3D0-B2284519C6F1Q35187902-3644C57A-7A21-4CF9-8713-64DB60E492DCQ36179528-8F04213E-7CAD-4DC6-88F1-F32B5B235B06Q36761677-1A33D842-8E70-4EC9-8B20-508777FC9CD4Q37969781-303DBE77-23E9-45E8-9FB2-90AB245C792EQ38156452-23CE8245-9240-4E69-9C80-B3647CAF7511Q38594695-20E40E73-F4D1-4FE3-AACE-5FB89D32FE55Q38656979-02053AF0-60A3-4201-8F49-271EDC67DD75Q46765992-6249463C-84DA-4073-9A95-59A8F650BC16Q46941434-10D9AC7F-E3DA-4B94-8E3B-8BE225DF66D5Q47965250-7A62AC67-FF37-438A-AC4F-4438D66C3084Q56760512-7212AEA6-2CC8-4833-B035-5B661EC503AF
P2860
Carbonyl reduction of naltrexone and dolasetron by oxidoreductases isolated from human liver cytosol.
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年学术文章
@wuu
2004年学术文章
@zh
2004年学术文章
@zh-cn
2004年学术文章
@zh-hans
2004年学术文章
@zh-my
2004年学术文章
@zh-sg
2004年學術文章
@yue
2004年學術文章
@zh-hant
name
Carbonyl reduction of naltrexo ...... ated from human liver cytosol.
@en
Carbonyl reduction of naltrexo ...... ated from human liver cytosol.
@nl
type
label
Carbonyl reduction of naltrexo ...... ated from human liver cytosol.
@en
Carbonyl reduction of naltrexo ...... ated from human liver cytosol.
@nl
prefLabel
Carbonyl reduction of naltrexo ...... ated from human liver cytosol.
@en
Carbonyl reduction of naltrexo ...... ated from human liver cytosol.
@nl
P2860
P356
P1476
Carbonyl reduction of naltrexo ...... ated from human liver cytosol.
@en
P2093
U Breyer-Pfaff
P2860
P304
P356
10.1211/0022357045020
P577
2004-12-01T00:00:00Z